MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-03-0004559
Pharmanza (India) Private Limited - pharma in Khambhat, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹75.33 Cr
▲ 11% YoY
Net profit · FY 2026
₹2.64 Cr
Net margin 3.5%
EBITDA · FY 2026
₹5.06 Cr
EBITDA margin 6.7%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.5 Cr
Issued & subscribed
Open charges
₹5.17 Cr
Satisfied ₹2.09 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
119
Provident fund records
About Pharmanza (India) Private Limited
Data last updated:
Pharmanza (India) Private Limited is a private limited company based in Khambhat, Gujarat, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 15 January 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2009PTC055895. Its GSTIN is 24AAECP9246J1Z4 (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors including Bhupendrabhai Jivabhai Patel (Managing Director) and Hardik Ravindrabhai Patel (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 70/1 G.I.D.C Estate Kansari, Khambhat, Gujarat, India – 388630.
As per the financials filed for FY 2026, the company reported a revenue of ₹75.33 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹2.64 Cr (net margin 3.5%) and EBITDA of ₹5.06 Cr (EBITDA margin 6.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 9% over five years.
The company has about 119 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pharmanza. As per MCA filings, the company has open charges of ₹5.17 Cr and satisfied charges of ₹2.09 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.15 Cr; the latest was in December 2023.
Pharmanza (India) Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-03-0004559). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmanza.com.
Company details
CIN U24230GJ2009PTC055895
Registration Number 055895
Incorporation Date 15 January 2009
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-03-0004559
Key People
Bhupendrabhai Jivabhai Patel Managing Director Hardik Ravindrabhai Patel Whole-Time Director Lal Lachhmandas Hingorani Director Recognitions & Rankings of Pharmanza (India)
Contact details
Pharmanza (India) Private Limited's registered office is in Khambhat, Gujarat. Its website is pharmanza.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address70/1 G.I.D.C Estate Kansari, Khambhat, Gujarat, India – 388630
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Pharmanza (India) Private Limited, buy the company report.
Comprehensive company report
Pharmanza (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Pharmanza (India) operates one associated brand: Pharmanza. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces and supplies veterinary drugs, antibiotics, and supplements for animal health. | pharmanza.com |
Business activity
The main business activity of Pharmanza (India) is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Pharmanza (India) Private Limited, buy the company report.
Financials of Pharmanza (India) Private Limited
FY 2026 filings availablePharmanza (India) Private Limited reported revenue of ₹75.33 Cr (up 11% YoY) for FY 2026.
Revenue · FY 2026
₹75.33 Cr ▲ 11%
Net profit · FY 2026
₹2.64 Cr margin 3.5%
EBITDA · FY 2026
₹5.06 Cr margin 6.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 10%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 20%
5 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 11% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹75.33 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.06 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.64 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmanza (India) Private Limited, buy the company report.
Board of directors of Pharmanza (India) Private Limited
Pharmanza (India) has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lal Lachhmandas Hingorani Also directs: Insat Pharma Private Limited, Pharmanza Herbal Private Limited | Director | 15 Jan 2009 | 17 Years 9 Months | Current |
| Bhupendrabhai Jivabhai Patel Also directs: Pharmanza Herbal Private Limited, Ayush Export Promotion Council | Managing Director | 15 Jan 2009 | 17 Years 9 Months | Current |
| Hardik Ravindrabhai Patel Also directs: Asn Hotel LLP, Insat Pharma Private Limited, Pharmanza Herbal Private Limited and 3 more | Whole-Time Director | 15 Jan 2009 | 17 Years 9 Months | Current |
| Kruti Viral Shah Also directs: Insat Pharma Private Limited | Director | 10 Nov 2023 | 2 Years 11 Months | Current |
Auditor
Pharmanza (India) Private Limited is audited by G. K. CHOKSI & CO. for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G. K. CHOKSI & CO. | FY 2026 | 101895W |
Shareholding
The shareholding of Pharmanza (India) Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharmanza (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.17 Cr
Satisfied charges
₹2.09 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2010 | 10242403 | Bank of India | ₹5.17 Cr | Open | |
| 09 Feb 2018 | 100190808 | Others | ₹21 Lakh | Satisfied | |
| 24 Jun 2009 | 10169521 | Indusind Bank Limited | ₹72.5 Lakh | Satisfied | |
| 05 Feb 2009 | 10139968 | The Dharmaj People Cooperative Bank Limited | ₹1.15 Cr | Satisfied |
To see the full charge records of Pharmanza (India) Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Pharmanza (India) Private Limited has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.15 Cr; the latest was in December 2023.
Total deals
5
Secondary share transfers
3
Funding rounds
2
Disclosed funding
₹1.15 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2014 | Funding round | ₹25 Lakh | Investors: 4 individuals |
| Mar 2010 | Funding round | ₹90 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pharmanza (India) Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Anand, Gujarat | Court case (REFER T LC) | Filed against the company by an individual | Disposed |
| District court, Anand, Gujarat | Court case (REFER-T-LC) | Filed against the company by an individual | Disposed |
To see the full case history of Pharmanza (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmanza (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pharmanza (India) Private Limited has a workforce of 119 employees on its EPFO records as of Mar 11, 2025, across 1 active EPFO establishment.
Employee count
119
Active EPFO establishments
1
Employee growth
-3.25%
GST
Pharmanza (India) has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECP9246J1Z4 | Gujarat | Active | 01 Jul 2017 |
| 05AAECP9246J1Z4 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pharmanza (India) Private Limited, buy the company report.
Recent activity
Pharmanza (India) Private Limited has 10 board changes on record since 2009: 5 appointments and 5 cessations. The latest: Kruti Viral Shah ceased to be Additional Director on 29 Sep 2024.
Filing
Pharmanza (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
AGM
Pharmanza (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Kruti Viral Shah ceased to be Additional Director.
Appointed
Kruti Viral Shah was appointed as Director.
Ceased
Vijaykumar Champaklal Shah ceased to be Director.
Charges
A charge registered on 09 Feb 2018 via Charge ID 100190808 with Others was fully satisfied on 09 Sep 2022.
Charges
A charge with Bank Of India of Rs. 5.17 Cr registered on 30 Aug 2010 with Charge ID 10242403 was modified on 29 Jun 2020.
Charges
A charge with Others amounted to Rs. 0.21 Cr with Charge ID 100190808 was registered on 09 Feb 2018.
Ceased
Bhupendrabhai Jivabhai Patel ceased to be Director.
Ceased
Hardik Ravindrabhai Patel ceased to be Director.
Ceased
Ravindrabhai Purshottambhai Patel ceased to be Additional Director.
Appointed
Ravindrabhai Purshottambhai Patel was appointed as Director.
9 earlier events are in the company report.
Frequently asked questions
Pharmanza (India) is an active private limited company based in Khambhat, Gujarat, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 15 January 2009 (17+ years old) and is registered under CIN U24230GJ2009PTC055895.
Pharmanza (India) has 4 current directors:
- Bhupendrabhai Jivabhai Patel - Managing Director
- Hardik Ravindrabhai Patel - Whole-Time Director
- Lal Lachhmandas Hingorani - Director
- Kruti Viral Shah - Director
The latest financial statements of Pharmanza (India) on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharmanza (India) is 24AAECP9246J1Z4, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAECP9246J1Z4 (Uttarakhand).
The CIN (Corporate Identification Number) of Pharmanza (India) is U24230GJ2009PTC055895. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmanza (India) has 2 court cases on record: 2 filed against it.
Pharmanza (India) was incorporated on 15 January 2009, making it 17+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Pharmanza (India) has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.15 Cr; the latest was in December 2023.
Kruti Viral Shah ceased to be Additional Director on 29 Sep 2024. Kruti Viral Shah was appointed as Director on 10 Nov 2023. Vijaykumar Champaklal Shah ceased to be Director on 29 Oct 2023. Pharmanza (India) has 10 board changes on record in total.
Yes, Pharmanza (India) is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-03-0004559).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages